T2

T2, chemically 3,5-diiodo-L-thyronine (3,5-T2), is a naturally occurring iodothyronine and an endogenous metabolite of the principal thyroid hormones thyroxine (T4) and triiodothyronine (T3). It carries two iodine atoms on the inner ring of the thyronine structure and is generated in the body through the sequential deiodination of thyroid hormones by iodothyronine deiodinase enzymes ^[6]. For many years it was regarded merely as an inactive breakdown product, but over the past two decades research has established that it exerts specific and biologically meaningful metabolic activities of its own ^[7].

Circulating 3,5-T2 is present in human serum at low nanomolar concentrations; in a large population study of euthyroid adults the median level was approximately 0.24 nM, and concentrations were associated with fasting glucose and thyrotropin (TSH) rather than with age, sex, or blood lipids ^[7]. This endogenous presence distinguishes T2 from fully synthetic thyromimetic drugs and underlies interest in it as a more physiological metabolic modulator.

Most experimental work on T2 has been conducted in rodent models of diet-induced obesity, fatty liver, and hypothyroidism, where administration rapidly stimulates basal metabolic rate, promotes fatty acid oxidation, prevents weight gain on a high-fat diet, and reverses hepatic steatosis ^[2][3][8]. A small proof-of-concept human study reported increases in resting metabolic rate and modest weight loss ^[1]. On the strength of these findings, T2 has been marketed as a dietary supplement and fat-loss aid, typically sold as an oral capsule or powder. It is not an approved medicine and remains an experimental compound outside mainstream clinical use; because it is a thyroid hormone metabolite, its use raises the possibility of thyroid-hormone-like activity that warrants caution ^[6].

T2 (3,5-diiodothyronine) is a thyroid hormone metabolite with thyromimetic activity, and in supraphysiologic amounts it can produce effects resembling hyperthyroidism. Risks include palpitations, tachycardia and arrhythmias, elevated blood pressure, tremor, and suppression of the body's own thyroid axis with lowered TSH; it can be especially hazardous for people with heart disease. The content of over-the-counter products is often unregulated and inconsistent, and long-term human safety data are lacking.

3,5-diiodo-L-thyronine, commonly abbreviated T2, is a naturally occurring metabolite formed in the body from the classical thyroid hormones, and for many years it was assumed to be biologically inert. Interest in its metabolic actions grew largely through work by Italian physiologists including Fernando Goglia, Antonia Lanni, and Maria Moreno at the University of Sannio and associated institutions, who from the 1990s onward reported that T2 could rapidly stimulate cellular respiration and energy expenditure.

Their studies, and a growing body of follow-up research, established that T2 acts predominantly through direct, non-genomic effects on mitochondria rather than by binding nuclear thyroid hormone receptors in the manner of stronger hormones. A small human study later reported increases in resting metabolic rate and modest weight loss while thyroid-stimulating hormone and the main thyroid hormones remained unchanged. Much of the robust evidence remains preclinical, a point reviewers have emphasized in summarizing the field.

T2 has earned an intriguing reputation as a metabolism-boosting compound that appears to accelerate fat burning while sidestepping much of the cardiac strain that limits the use of stronger thyroid hormones. Researchers find it fascinating because it seems to work directly at the mitochondrial level, rapidly raising energy expenditure and driving hepatic fat oxidation in laboratory models.

It is often highlighted for a small human trial in which resting metabolic rate rose and body weight fell by roughly four percent while TSH and thyroid hormone levels stayed put and no adverse cardiac effects were detected, an unusually clean result for a thyroid-related compound. In fairness, most of the strongest data still come from rodents, and T2 retains the potential for thyroid-hormone-like effects if intake is high. It remains a genuinely promising but still incompletely studied member of the metabolic-support category.